HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-APR-17 5VGO TITLE BRUTON'S TYROSINE KINASE (BTK) WITH COMPOUND G-744 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 427-691; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.YU,C.EIGENBROT REVDAT 2 04-OCT-23 5VGO 1 REMARK REVDAT 1 05-JUL-17 5VGO 0 JRNL AUTH X.WANG,J.BARBOSA,P.BLOMGREN,M.C.BREMER,J.CHEN,J.J.CRAWFORD, JRNL AUTH 2 W.DENG,L.DONG,C.EIGENBROT,S.GALLION,J.HAU,H.HU,A.R.JOHNSON, JRNL AUTH 3 A.KATEWA,J.E.KROPF,S.H.LEE,L.LIU,J.W.LUBACH,J.MACALUSO, JRNL AUTH 4 P.MACIEJEWSKI,S.A.MITCHELL,D.F.ORTWINE,J.DIPAOLO,K.REIF, JRNL AUTH 5 H.SCHEERENS,A.SCHMITT,H.WONG,J.M.XIONG,J.XU,Z.ZHAO,F.ZHOU, JRNL AUTH 6 K.S.CURRIE,W.B.YOUNG JRNL TITL DISCOVERY OF POTENT AND SELECTIVE TRICYCLIC INHIBITORS OF JRNL TITL 2 BRUTON'S TYROSINE KINASE WITH IMPROVED DRUGLIKE PROPERTIES. JRNL REF ACS MED CHEM LETT V. 8 608 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28626519 JRNL DOI 10.1021/ACSMEDCHEMLETT.7B00103 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.890 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 36418 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1873 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.9210 - 3.8108 1.00 2769 136 0.1445 0.1427 REMARK 3 2 3.8108 - 3.0249 1.00 2684 148 0.1449 0.1673 REMARK 3 3 3.0249 - 2.6426 1.00 2641 156 0.1694 0.1884 REMARK 3 4 2.6426 - 2.4010 1.00 2705 134 0.1715 0.1948 REMARK 3 5 2.4010 - 2.2289 1.00 2657 135 0.1606 0.2080 REMARK 3 6 2.2289 - 2.0975 1.00 2646 150 0.1610 0.2033 REMARK 3 7 2.0975 - 1.9924 1.00 2670 132 0.1646 0.1939 REMARK 3 8 1.9924 - 1.9057 1.00 2607 154 0.1705 0.2062 REMARK 3 9 1.9057 - 1.8323 1.00 2666 133 0.1768 0.2346 REMARK 3 10 1.8323 - 1.7691 1.00 2626 150 0.1884 0.2274 REMARK 3 11 1.7691 - 1.7138 1.00 2652 147 0.1952 0.2398 REMARK 3 12 1.7138 - 1.6648 1.00 2639 148 0.2128 0.2512 REMARK 3 13 1.6648 - 1.6210 0.99 2583 150 0.2404 0.2652 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2399 REMARK 3 ANGLE : 1.052 3251 REMARK 3 CHIRALITY : 0.042 335 REMARK 3 PLANARITY : 0.004 409 REMARK 3 DIHEDRAL : 13.928 927 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VGO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227397. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36419 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 46.901 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 10.10 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04770 REMARK 200 FOR THE DATA SET : 28.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.92900 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 4RX5 REMARK 200 REMARK 200 REMARK: RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR 0.1 M LISO4, 0.1 M CITRIC REMARK 280 ACID PH 5.5, 6% PEG 10K, 0.4% BETA-OCTYLGLUCOSIDE PROTEIN 8 MG/ REMARK 280 ML 10 MM TRIS 8.5, 0.1 M NACL, 0.5 MM TCEP, G-744 MADE 0.5 MM REMARK 280 USING 10 MM DMSO STOCK DROP 1:2 PROTEIN/RESERVOIR., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 14.19000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.38000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.28500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 35.47500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 7.09500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 392 REMARK 465 GLY A 393 REMARK 465 LEU A 659 REMARK 465 TYR A 660 REMARK 465 PHE A 661 REMARK 465 GLN A 662 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 811 O HOH A 899 2564 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -9.42 79.92 REMARK 500 ARG A 520 -12.74 82.67 REMARK 500 ASP A 521 52.38 -148.79 REMARK 500 ASP A 548 103.23 -172.44 REMARK 500 ARG A 600 -15.92 81.79 REMARK 500 ARG A 600 -15.78 81.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG0 A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG0 A 706 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9B1 A 707 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VFI RELATED DB: PDB DBREF 5VGO A 393 657 UNP Q06187 BTK_HUMAN 427 691 SEQADV 5VGO MET A 392 UNP Q06187 EXPRESSION TAG SEQADV 5VGO ASN A 658 UNP Q06187 EXPRESSION TAG SEQADV 5VGO LEU A 659 UNP Q06187 EXPRESSION TAG SEQADV 5VGO TYR A 660 UNP Q06187 EXPRESSION TAG SEQADV 5VGO PHE A 661 UNP Q06187 EXPRESSION TAG SEQADV 5VGO GLN A 662 UNP Q06187 EXPRESSION TAG SEQRES 1 A 271 MET GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE SEQRES 2 A 271 LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS SEQRES 3 A 271 TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS SEQRES 4 A 271 MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE SEQRES 5 A 271 GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS SEQRES 6 A 271 LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO SEQRES 7 A 271 ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU SEQRES 8 A 271 LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR SEQRES 9 A 271 GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA SEQRES 10 A 271 MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP SEQRES 11 A 271 LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL SEQRES 12 A 271 VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU SEQRES 13 A 271 ASP ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO SEQRES 14 A 271 VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS SEQRES 15 A 271 PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU SEQRES 16 A 271 MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU SEQRES 17 A 271 ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN SEQRES 18 A 271 GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS SEQRES 19 A 271 VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA SEQRES 20 A 271 ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE SEQRES 21 A 271 LEU ASP VAL MET ASP GLU ASN LEU TYR PHE GLN HET SO4 A 701 5 HET SO4 A 702 5 HET GOL A 703 6 HET GOL A 704 6 HET PG0 A 705 8 HET PG0 A 706 8 HET 9B1 A 707 38 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM PG0 2-(2-METHOXYETHOXY)ETHANOL HETNAM 9B1 2-[2-(HYDROXYMETHYL)-3-{1-METHYL-6-OXO-5-[(PYRIMIDIN-4- HETNAM 2 9B1 YL)AMINO]-1,6-DIHYDROPYRIDIN-3-YL}PHENYL]-6,6- HETNAM 3 9B1 DIMETHYL-3,4,6,7-TETRAHYDRO-2H-CYCLOPENTA[4, HETNAM 4 9B1 5]THIENO[2,3-C]PYRIDIN-1(5H)-ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN PG0 PEG 6000 FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 PG0 2(C5 H12 O3) FORMUL 8 9B1 C29 H29 N5 O3 S FORMUL 9 HOH *272(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 CYS A 481 MET A 489 1 9 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ALA A 523 ARG A 525 5 3 HELIX 6 AA6 GLY A 541 VAL A 546 5 6 HELIX 7 AA7 ASP A 548 SER A 553 1 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 ASN A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LEU A 405 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 -2.14 SITE 1 AC1 4 LYS A 466 ARG A 490 HOH A 803 HOH A 855 SITE 1 AC2 7 SER A 592 LYS A 595 TYR A 617 PRO A 619 SITE 2 AC2 7 HIS A 620 HOH A 810 HOH A 868 SITE 1 AC3 8 ILE A 443 GLU A 444 ARG A 562 MET A 596 SITE 2 AC3 8 ARG A 600 PHE A 601 THR A 602 HOH A 924 SITE 1 AC4 9 ARG A 520 SER A 543 TYR A 551 PHE A 559 SITE 2 AC4 9 PRO A 560 PHE A 574 HOH A 814 HOH A 824 SITE 3 AC4 9 HOH A 845 SITE 1 AC5 3 TYR A 425 TYR A 461 HOH A 904 SITE 1 AC6 6 ARG A 468 GLY A 480 CYS A 481 ASN A 484 SITE 2 AC6 6 9B1 A 707 HOH A 848 SITE 1 AC7 18 LEU A 408 GLY A 411 PHE A 413 VAL A 416 SITE 2 AC7 18 ALA A 428 LYS A 430 THR A 474 GLU A 475 SITE 3 AC7 18 TYR A 476 MET A 477 ALA A 478 GLY A 480 SITE 4 AC7 18 ASN A 526 LEU A 528 ASP A 539 TYR A 551 SITE 5 AC7 18 PG0 A 706 HOH A 942 CRYST1 108.314 108.314 42.570 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009232 0.005330 0.000000 0.00000 SCALE2 0.000000 0.010661 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023491 0.00000